Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 32

Sort by

Sort Order Select

Journal Articles

Clinical Characteristics, Molecular Features and Transplantation Outcomes in MDS with Low Blasts and without Defining Genetic Abnormalities: An Analysis of MDS-h and MDS-LB Patients

Wenjing Guo, Li Jia, Yingchang Mi, Sizhou Feng

Blood (2024) 144 (Supplement 1): 7444.

https://doi.org/10.1182/blood-2024-210574

Published: 2024

Journal Articles

Incidence, Risk Factors, Microbiology and Outcomes of Bloodstream Infection during Conditioning before Allogeneic Hematopoietic Stem Cell Transplantation

Ling Pan, Li Jia, Xiaomeng Feng, Erlie Jiang, Sizhou Feng

Blood (2024) 144 (Supplement 1): 7287.

https://doi.org/10.1182/blood-2024-204385

Published: 2024

Journal Articles

Clinical and Genetic Profiles and Outcomes of Allogeneic HSCT in Secondary Myelodysplastic Syndrome Following Aplastic Anemia

Li Jia, Erlie Jiang, Sizhou Feng

Blood (2024) 144 (Supplement 1): 7423.

https://doi.org/10.1182/blood-2024-198333

Published: 2024

Journal Articles

Haematopoietic Stem Cell Transplantation for Hepatitis-Associated Aplastic Anaemia: Clinical Characteristics, Outcomes and Risk Factors

Li Jia, Yilin Liu, Erlie Jiang, Sizhou Feng

Blood (2023) 142 (Supplement 1): 7105.

https://doi.org/10.1182/blood-2023-188427

Published: 2023

Journal Articles

Discovery and Preclinical Study of Novel BTK Degrader HZ-Q1060

Xingguo Liu, Yubo Zhou, Yizhe Wu, Xiaomin Luo, Jiangfeng Xie, Xinxin Jin, Haiyan Yang, Li Jia, Xinglu Zhou

Blood (2022) 140 (Supplement 1): 4942.

https://doi.org/10.1182/blood-2022-167308

Published: 2022

Journal Articles

Phase 1 Study of Bisthianostat, an Orally Efficacious Pan-HDAC Inhibitor: Part Results of Safety, Pharmacokinetics and Efficacy in Patients with Relapsed or Refractory Multiple Myeloma

Hong-Hui Huang, PhD MD, Jian Hou, PhD MD, Yang-Ming Zhang, PhD, Yu-Bo Zhou, PhD, Li Jia, PhD, Fa-Jun Nan, PhD

Blood (2019) 134 (Supplement_1): 5591.

https://doi.org/10.1182/blood-2019-129683

Published: 2019

Journal Articles

Developing the Next Generation of iPSC Cell-Based Immunotherapies

Raul Vizcardo, PhD, Nicholas Donald Klemen, MD, Rafiqul Islam, PhD, Devikala Gurusamy, PhD, Naritaka Tamaoki, MD, PhD, Li Jia, PhD, Zhiya Yu, PhD, Amanda N Hennings, PhD, Takuya Maeda, MD, Marta Bosch-Marce, PhD, Meghan L Good, MD, Svetlana Pack, PhD, David F. Stroncek, Francis A Flomerfelt, PhD, Michael J Kruhlak, PhD, Nicholas Phillip Restifo, MD

Blood (2018) 132 (Supplement 1): 3707.

https://doi.org/10.1182/blood-2018-99-118593

Published: 2018

Journal Articles

Inhibition of B-Cell Receptor Signaling Disrupts Cell Adhesion in Mantle Cell Lymphoma Via RAC2

Weige Wang, MD, Franzen Carrie, Hui Guo, PhD, Jimmy Lee, MD, Yan Li, Madina Sukhanova, PhD, Dong Sheng, MD, Girish Venkataraman, MD MBBS, Ming Mei, Pin Lu, PhD, Anhui Gao, Chunmei Xia, Li Jia, Liang Zhang, MD PhD, Michael Wang, MD, Jorge Andrade, Zhou Xiaoyan, Y. Lynn Lynn Wang, MDPhD

Blood (2018) 132 (Supplement 1): 1369.

https://doi.org/10.1182/blood-2018-99-118598

Published: 2018

Journal Articles

The Novel HDAC Inhibitor Chidamide Synergizes with Rituximab to Inhibit DLBCL Tumor Growth in Vitro and In Vivo By up-Regulating CD20 Expression

Xu-Wen Guan, MD, Wang Hua-Qing, MD PhD, Li Jia, MD PhD, Feng-Ting Liu, MB, PhD

Blood (2018) 132 (Supplement 1): 2947.

https://doi.org/10.1182/blood-2018-99-114598

Published: 2018

Journal Articles

Increased Levels of Soluble RAGE in CLL Patient Plasma Has a Protective Effect on CLL Disease Progression

Faith Norster, Robert Petty, PhD, John G. Gribben, MDDSc FMedSci, Li Jia, MD PhD

Blood (2017) 130 (Supplement 1): 4292.

https://doi.org/10.1182/blood.V130.Suppl_1.4292.4292

Published: 2017

Journal Articles

RAC2 Links B-Cell Receptor Signaling and Cell Adhesion in Mantle Cell Lymphoma

Weige Wang, Franzen Carrie, Madina Sukhanova, Venkataraman Girish, Ming Mei, Guo Ailin, Pin Lu, PhD, Dong Sheng, MD, Gao Anhui, Xia Chunmei, Li Jia, Zhou Xiaoyan, Y Lynn Wang

Blood (2017) 130 (Supplement 1): 2752.

https://doi.org/10.1182/blood.V130.Suppl_1.2752.2752

Published: 2017

Journal Articles

Overexpression of HMGB1 Receptor RAGE Is Associated with Worse Clinical Outcome in Patients with Chronic Lymphocytic Leukemia

Faith Norster, MBiochem, Andrew James Clear, BSc, Janet Matthews, Elena Hoxha, MSc, John Gribben, MDDSc, Li Jia, PhD MD

Blood (2015) 126 (23): 617.

https://doi.org/10.1182/blood.V126.23.617.617

Published: 2015

Journal Articles

Overexpression of BCL-2 Does Not Inhibit Autophagy in Human Follicular and Diffuse Large B-Cell Lymphomas

Aine McCarthy, PhD, Andrew James Clear, BSc, Jacek Marzec, Rita Coutinho, MD, Robert D. Petty, PhD, Janet Matthews, Andrew Wilson, Sameena Iqbal, Maria Calaminici, MD PhD, John G. Gribben, MD DSc, Li Jia, PhD MD

Blood (2014) 124 (21): 3007.

https://doi.org/10.1182/blood.V124.21.3007.3007

Published: 2014

Journal Articles

ZRSR2 Mutations Cause Dysregulated RNA Splicing in MDS

Vikas Madan, PhD, Deepika Kanojia, PhD, Li Jia, Ryoko Okamoto, PhD, Aiko Sato-Otsubo, Alexander Kohlmann, PhD, Masashi Sanada, MD PhD, Vera Grossmann, Janani Sundaresan, Yuichi Shiraishi, PhD, Satoru Miyano, PhD, Felicitas Thol, MD, Arnold Ganser, Henry Yang, PhD, Torsten Haferlach, Seishi Ogawa, MD PhD, H. Phillip Koeffler

Blood (2014) 124 (21): 4609.

https://doi.org/10.1182/blood.V124.21.4609.4609

Published: 2014

Journal Articles

Dangerous power: mitochondria in CLL cells

Li Jia, John G. Gribben

Blood (2014) 123 (17): 2596–2597.

https://doi.org/10.1182/blood-2014-03-558965

Published: 2014

Journal Articles

Extracellular HMGB1 promotes differentiation of nurse-like cells in chronic lymphocytic leukemia

Li Jia, Andrew Clear, Feng-Ting Liu, Janet Matthews, Nadiha Uddin, Aine McCarthy, Elena Hoxha, Catherine Durance, Sameena Iqbal, John G. Gribben

Blood (2014) 123 (11): 1709–1719.

https://doi.org/10.1182/blood-2013-10-529610

Published: 2014

Includes: Supplemental data

Journal Articles

Tocilizumab Overcomes Chemo-Resistance Of CLL Cells

Fengting Liu, MD Ph.D, Li Jia, PhD, MD, Ping Wang, MD, Tim Farren, PhD, Samir G Agrawal, MD, PhD

Blood (2013) 122 (21): 5305.

https://doi.org/10.1182/blood.V122.21.5305.5305

Published: 2013

Journal Articles

Inhibition of Autophagy by Chloroquine Sensitises Lymphoma Cells to ABT-737-Induced Apoptosis

Aine McCarthy, Vincent Yeung, John G. Gribben, MD, DSc, FRCP, FMedSci, FRCPath, Li Jia, PhD, MD

Blood (2012) 120 (21): 1625.

https://doi.org/10.1182/blood.V120.21.1625.1625

Published: 2012

Journal Articles

HMGB1 Activates TLR9/RAGE Signalling Pathway and Sustains Chronic Lymphocytic Leukemic Cell in Vitro Survival

Amani Al-Malti, John G. Gribben, MD, DSc, FRCP, FMedSci, FRCPath, Li Jia, PhD, MD

Blood (2012) 120 (21): 3860.

https://doi.org/10.1182/blood.V120.21.3860.3860

Published: 2012

Journal Articles

Autocrine IL-6 Production Indicates the Level of Activated STAT3 and NF-Kb of Chronic Lymphocytic Leukemia Cells

Fengting Liu, Li Jia, MD, PhD, Timothy W Farren, John G. Gribben, MD, DSc, Samir G Agrawal, MD, PhD

Blood (2011) 118 (21): 1784.

https://doi.org/10.1182/blood.V118.21.1784.1784

Published: 2011

NARROW

Clinical Characteristics, Molecular Features and Transplantation Outcomes in MDS with Low Blasts and without Defining Genetic Abnormalities: An Analysis of MDS-h and MDS-LB Patients

Incidence, Risk Factors, Microbiology and Outcomes of Bloodstream Infection during Conditioning before Allogeneic Hematopoietic Stem Cell Transplantation

Clinical and Genetic Profiles and Outcomes of Allogeneic HSCT in Secondary Myelodysplastic Syndrome Following Aplastic Anemia

Haematopoietic Stem Cell Transplantation for Hepatitis-Associated Aplastic Anaemia: Clinical Characteristics, Outcomes and Risk Factors

Discovery and Preclinical Study of Novel BTK Degrader HZ-Q1060

Phase 1 Study of Bisthianostat, an Orally Efficacious Pan-HDAC Inhibitor: Part Results of Safety, Pharmacokinetics and Efficacy in Patients with Relapsed or Refractory Multiple Myeloma

Developing the Next Generation of iPSC Cell-Based Immunotherapies

Inhibition of B-Cell Receptor Signaling Disrupts Cell Adhesion in Mantle Cell Lymphoma Via RAC2

The Novel HDAC Inhibitor Chidamide Synergizes with Rituximab to Inhibit DLBCL Tumor Growth in Vitro and In Vivo By up-Regulating CD20 Expression

Increased Levels of Soluble RAGE in CLL Patient Plasma Has a Protective Effect on CLL Disease Progression

RAC2 Links B-Cell Receptor Signaling and Cell Adhesion in Mantle Cell Lymphoma

Overexpression of HMGB1 Receptor RAGE Is Associated with Worse Clinical Outcome in Patients with Chronic Lymphocytic Leukemia

Overexpression of BCL-2 Does Not Inhibit Autophagy in Human Follicular and Diffuse Large B-Cell Lymphomas

ZRSR2 Mutations Cause Dysregulated RNA Splicing in MDS

Dangerous power: mitochondria in CLL cells

Extracellular HMGB1 promotes differentiation of nurse-like cells in chronic lymphocytic leukemia

Tocilizumab Overcomes Chemo-Resistance Of CLL Cells

Inhibition of Autophagy by Chloroquine Sensitises Lymphoma Cells to ABT-737-Induced Apoptosis

HMGB1 Activates TLR9/RAGE Signalling Pathway and Sustains Chronic Lymphocytic Leukemic Cell in Vitro Survival

Autocrine IL-6 Production Indicates the Level of Activated STAT3 and NF-Kb of Chronic Lymphocytic Leukemia Cells

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only